Early Adoption of Dupilumab in the Medicare Population in 2017.
Year: 2020
Type: article
Abstract: : There are differences in access to dupilumab in the Medicare population based on geographic location in the US. Trends of decreased access to novel dermatologic biologics in rural areas of the US may begin at their introduction to the market, identifying a potential target for future interventions to equalize access.
Source: PubMed
Authors: Shayan Cheraghlou, Jeffrey M Cohen
Institution: Yale University
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W3114370551
